SpectraBase Spectrum ID |
DkEnb4scdnM |
Name |
Sibutramine |
CAS Registry Number |
106650-56-0 |
Classification |
Pharmaceutical drug (withdrawn marketing approval), anorectic |
Comments |
Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.14 (f) (12) |
DEA Controlled Substance Name |
Sibutramine |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
1675 |
DEA Schedule |
Schedule IV |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers |
Exact Mass |
279.175377541 u |
Formula |
C17H26ClN |
InChI |
InChI=1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3 |
InChIKey |
UNAANXDKBXWMLN-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
279.855 g/mol |
Nominal Mass |
279 u |
Quality |
996 |
Retention Index |
1859 |
SMILES |
C1(C(CC(C)C)N(C)C)(C2=CC=C(C=C2)Cl)CCC1 |
SPLASH |
splash10-03di-3900000000-5fd40d492a2b9aa59d35 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
Reductil
1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan-1-amine |
Technique |
GC/MS |
Wiley ID |
DD2024_003894 |